Utility of echocardiographic measurement in assessing pulmonary arterial hypertension (PH) in COPD and correlation with severity and potential risk of acute exacerbation within 30 days

O Asma; A Sana; B Wafa; K Asma; B J Rahma; K Amani; G Imene; A Ahmed; H Abdelaziz

doi:10.1183/13993003.congress-2022.4288

Abstract

Introduction: Pulmonary hypertension (PH) commonly complicates the course of patients with chronic obstructive pulmonary disease (COPD). It has a significant impact on prognosis and is, therefore, important to detect.

Materials and method: We studied the records of 279 patients (2020–2022) who were admitted for COPD acute exacerbation and stratified into 2 groups: G1: those who have a pulmonary hypertension (PH), G2: those without (PH). PH was defined as TTPG ≥25 mmHg.

Results: The mean age was 66.1 years old and 46 patients were females. There were 110 patients with available echocardiography. 78 patients were included in G1. COPD-PH patients had higher rates of long stay in hospital (p=0.025) and higher risk of exacerbation within 30 days (p=0.032) compared to COPD alone.

Conclusion: Considering the prognostic and therapeutic implications of cardiac comorbidity, echocardiography should be considered in the assessment of patients with clinically significant COPD.

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 4288.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).